225 Summit AvenueMontvale, NJ 07645
Overview of Dr. Kriplani
Dr. Anuja Kriplani is a Medical Oncologist treating Head and Neck Cancers as well as Non-Melanoma Skin Cancers at Memorial Sloan Kettering Cancer Center. She completed her education at the State University of New York Downstate Medical Center College of Medicine in 2011, and went on to specialize in Internal Medicine at SUNY Health Science Center at Brooklyn from 2011 to 2014. She served as Internal Medicine Chief Resident at Memorial Sloan Kettering Cancer Center from 2014 to 2015. She further specialized in Hematology and Medical Oncology from 2015 to 2018 at the Icahn School of Medicine at Mount Sinai. Apart from her clinical practice, Dr. Kriplani is an active researcher, contributing to the body of medical literature with several publications on topics like pain management in cancer survivors, treatment approaches to human papillomavirus-associated oropharyngeal cancer, safety of opioid prescribing in older cancer patients, among others. Her work has been recognized and cited multiple times by other researchers.
Education & Training
Icahn School of Medicine at Mount SinaiFellowship, Hematology and Medical Oncology, 2015 - 2018
Memorial Sloan Kettering Cancer CenterChief Resident, 2014 - 2015
SUNY Downstate Health Sciences UniversityResidency, Internal Medicine, 2011 - 2014
State University of New York Downstate Medical Center College of MedicineClass of 2011
Certifications & Licensure
FL State Medical License 2021 - Present
NJ State Medical License 2018 - 2027
NY State Medical License 2014 - 2027
CT State Medical License 2023 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Impact of an Electronic Patient-Reported Outcome-Informed Clinical Decision Support Tool on Clinical Discussions With Head and Neck Cancer Survivors: Findings From the...Talya Salz, Emily V Dressler, Carol Kittel, Andrew Salner, Deborah K Mayer
JCO Oncology Practice. 2025-10-21 - A phase 1/1b study of lenvatinib and cetuximab in patients with recurrent/metastatic head and neck squamous cell carcinoma.Lara A Dunn, Alan L Ho, Loren S Michel, Winston Wong, Juliana Eng
Oral Oncology. 2025-10-01 - Prospective Trial Evaluating Post-operative Human Papilloma Virus Circulating Tumor DNA Guided Adjuvant Therapy for Human Papilloma Virus-related Oropharyngeal Carcino...Linda Chen, Marc Cohen, Vaios Hatzglou, Zhigang Zhang, Nadeem Riaz
International Journal of Radiation Oncology, Biology, Physics. 2025-10-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
